Clinical Trial Update: A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial of the investigational agent Ivonescimab for advanced, metastatic salivary gland cancers that is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Salivary Gland Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Glenn J. Hanna | Conditions: Salivary Gland Cancer, Advanced Salivary Gland Carcinoma | Phase 2 | Status: RECRUITING